From ERα66 to ERα36: a new predictive marker for cancer progression and therapeutic response in breast tumors ?

Charlène Thiébaut (1) , Chloé Morel (1) , Alexandre Harlé (2, 1) , Amand Chesnel (1) , Agnès Leroux (2) , Clémence Chamard-Jovenin (1) , Taha Boukhobza (1) , Jean-Louis Merlin (2, 1) , Hélène Dumond (1)

1 CRAN - Centre de Recherche en Automatique de Nancy
2 UNICANCER/ICL - Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy]

Domaines: Cancer

Charlène Thiébaut, Chloé Morel, Alexandre Harlé, Amand Chesnel, Agnès Leroux, et al.. From ERα66 to ERα36: a new predictive marker for cancer progression and therapeutic response in breast tumors ?. Colloque Interrégional Grand-Est de Recherche Translationnelle en Oncologie ONCOTRANS, CGE, Feb 2017, Besançon, France. ⟨hal-01667636⟩